Open Innovation Opportunity

Existing Project

The Swiss Data Science Center (ETH Zurich and EPFL) is conducting a brief survey to gather insights of how organizations like yours are leveraging Artificial Intelligence (AI) in the field of drug discovery and development. Your participation will contribute significantly to our research and comprehensive industry overview. Respecting your busy schedule, we've ensured that this survey is concise, requiring just 5 minutes to complete.

Survey Link:

To express our gratitude for your participation:
- We are pleased to offer you a complimentary ticket to the upcoming SDSC-Connect event “AI for Precision Medicine”, on the 30th of May, 2024 at EPFL (Lausanne, Switzerland). This event is a networking and knowledge sharing opportunity with biomedical, pharma and biotech leaders.
- We will also provide a summarized report of the survey findings once all responses have been collected. This summary will offer you a valuable perspective on how pharma and biotech companies use AI in their drug discovery & development innovations.

Paperclip Icon

660d6c56b9852_Figure 1.png